Abstract
Matrix metalloproteinases (MMPs) have been implicated in both normal and pathologic processes. In cancer in particular, in vitro and animal studies showed an involvement of MMPs in many stages of cancer progression. This led to the development of MMP inhibitors that in most cases failed in clinical trials. In this review we go over the role of MMPs in the different stages of cancer progression and try to understand why the early generation of MMP inhibitors failed. The analysis of the lessons from this first experience, plus the review of the current knowledge that shows that MMPs may be pro-or anti-tumorigenic may set the stage for a future success for this therapeutic strategy in cancer.
Keywords: Cancer, clinical trials, matrix metalloproteinases, MMP inhibitors, therapy, therapeutic strategy, anti-tumorigenic, Malignant tumors, bind amino acid, glycosylphosphatidylinositol anchor, vascular and inflammatory cells, plasminogen-null mice, intramolecular autolytic, plasminogen-activating enzyme, Plasmin
Current Pharmaceutical Biotechnology
Title: Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances
Volume: 12 Issue: 11
Author(s): D. Raffo, O. Pontiggia and M. Simian
Affiliation:
Keywords: Cancer, clinical trials, matrix metalloproteinases, MMP inhibitors, therapy, therapeutic strategy, anti-tumorigenic, Malignant tumors, bind amino acid, glycosylphosphatidylinositol anchor, vascular and inflammatory cells, plasminogen-null mice, intramolecular autolytic, plasminogen-activating enzyme, Plasmin
Abstract: Matrix metalloproteinases (MMPs) have been implicated in both normal and pathologic processes. In cancer in particular, in vitro and animal studies showed an involvement of MMPs in many stages of cancer progression. This led to the development of MMP inhibitors that in most cases failed in clinical trials. In this review we go over the role of MMPs in the different stages of cancer progression and try to understand why the early generation of MMP inhibitors failed. The analysis of the lessons from this first experience, plus the review of the current knowledge that shows that MMPs may be pro-or anti-tumorigenic may set the stage for a future success for this therapeutic strategy in cancer.
Export Options
About this article
Cite this article as:
Raffo D., Pontiggia O. and Simian M., Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances, Current Pharmaceutical Biotechnology 2011; 12 (11) . https://dx.doi.org/10.2174/138920111798377085
DOI https://dx.doi.org/10.2174/138920111798377085 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neuroprotection and Regeneration Strategies for Spinal Cord Repair
Current Pharmaceutical Design Yielding Criterion of Porcine Thoracic Aorta
Recent Patents on Cardiovascular Drug Discovery The Importance of Reendothelialization After Arterial Injury
Current Pharmaceutical Design Hereditary Haemorrhagic Teleangiectasia: Diagnostic Imaging of Visceral Involvement
Current Pharmaceutical Design Alport Syndrome: A Comprehensive Review on Genetics, Pathophysiology, Histology, Clinical and Therapeutic Perspectives
Current Medicinal Chemistry Natural Products to Anti-trypanosomal Drugs: An Overview of New Drug Prototypes for American Trypanosomiasis
Cardiovascular & Hematological Agents in Medicinal Chemistry Matrix Metalloproteinases and Vulnerable Atheromatous Plaque
Current Topics in Medicinal Chemistry Anticoagulation in Patients with Heart Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry Stereotactic Body Radiotherapy in the Management of Head and Neck Malignancies
Current Cancer Therapy Reviews Single Photon Emission Tomography in the Diagnostic Assessment of Cardiac and Vascular Infectious Diseases
Current Radiopharmaceuticals Biological, Geometric and Biomechanical Factors Influencing Abdominal Aortic Aneurysm Rupture Risk: A Comprehensive Review
Recent Patents on Medical Imaging Bioactive Compound and Nanotechnology: A Novel Delivery Perspective for Diabetic Retinopathy
Current Bioactive Compounds Contributory Role of Matrix Metalloproteinases in Cardiovascular Remodeling
Current Drug Targets - Cardiovascular & Hematological Disorders Triglycerides and Vascular Risk: Insights from Epidemiological Data and Interventional Studies
Current Drug Targets Effects of Erythropoietin on Brain Function
Current Pharmaceutical Biotechnology Cultivating Software Solutions Development in the Scientific Academia
Recent Patents on Computer Science Cardiac Remodeling Induced by Smoking: Concepts, Relevance, and Potential Mechanisms
Inflammation & Allergy - Drug Targets (Discontinued) Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy Gender as a Regulator of Atherosclerosis in Murine Models
Current Drug Targets Cerebrovascular Diseases in HIV-Infected Patients
Current HIV Research